Schizophrenia

  • Most Topular Stories

  • Aspirin shown to benefit schizophrenia treatment

    Schizophrenia News
    20 Oct 2014 | 7:55 am
    A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.
  • WCPG 2014 Genomics Smorgasbord: Varied Samplings for Schizophrenia

    Schizophrenia Research Forum: Research News
    15 Oct 2014 | 10:00 pm
    The 25th annual World Congress of Psychiatric Genetics got underway in Copenhagen, Denmark, on October 11...
  • The Difference between Schizophrenia and...

    About.com Schizophrenia: What's Hot Now
    schizophrenia.guide@about.com
    22 Oct 2014 | 4:24 am
    Schizophrenia and schizoaffective are two different disorders. This article discusses the relevant differences why that matters.
  • The 12 Core Functions: Your Therapist and Treatment Path

    Schiz Life
    Schiz Life
    20 Jul 2014 | 5:43 am
    The 12 Core Functions: Your Therapist and Treatment Path A sad reality is that many people dealing with the symptoms of schizophrenia simply fail to receive treatment.  There are lots of various reasons why this can happen, but one of the reasons is a resistance and fear in not understanding how treatment will transpire.  This article is meant to give the reader a general overview of what the therapist is thinking and the guidelines they follow to perform their task.  Your treatment will be personalized and tailored specifically to your experiences, symptoms, and receptiveness, but it will…
  • WCPG 2014 Stem Cells Gather Steam

    Schizophrenia Research Forum: Research News
    16 Oct 2014 | 10:00 pm
    A session devoted to induced pluripotent stem cells (iPSCs) for modeling neuropsychiatric disease marked "a new era in psychiatric genetics,"...
  • add this feed to my.Alltop

    Schizophrenia News

  • FDA Accepts New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia

    22 Oct 2014 | 12:41 pm
    The FDA has accepted for filing a new drug application for aripiprazole lauroxil , an investigational, once-monthly injectable atypical antipsychotic for the treatment of schizophrenia. Under the Prescription Drug User Fee Act , the FDA's target action date for the aripiprazole lauroxil NDA is August 22, 2015.
  • Ameritox and Ingenuity Health Expand Effort to Help Assess Medication ...

    21 Oct 2014 | 2:12 pm
    Ameritox , the nation's leader in medication monitoring solutions, today launched a method to help assess medication adherence in behavioral health patients prescribed the antipsychotic drug risperidone ). This new method marks a critical step toward establishing a comprehensive reference database for commonly prescribed antipsychotic medications, providing behavioral health clinicians help in addressing the acute problem of medication non-adherence in those with serious mental illness.
  • Omeros Provides Update on PDE10 Inhibitor Program

    21 Oct 2014 | 6:31 am
    Omeros Corporation today provided an update on OMS824, the company's phosphodiesterase 10 inhibitor in development for the treatment of schizophrenia and Huntington's disease. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition.
  • Aspirin, Anti-Inflammatory Medicine, Benefits Schizophrenia Treatment

    20 Oct 2014 | 11:48 am
    Anti-inflammatory medicines such as aspirin, estrogen, and Fluimucil can improve the efficacy of existing schizophrenia treatments, according to results announced at the European College of Neuropsychopharmacology conference in Berlin. Doctors have long believed that helping the immune system may benefit the treatment of schizophrenia, but until now there has been no conclusive evidence that this would be effective.
  • Aspirin shown to benefit schizophrenia treatment

    20 Oct 2014 | 7:55 am
    A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.
 
 
  • add this feed to my.Alltop

    About.com Schizophrenia: What's Hot Now

  • The Difference between Schizophrenia and...

    schizophrenia.guide@about.com
    22 Oct 2014 | 4:24 am
    Schizophrenia and schizoaffective are two different disorders. This article discusses the relevant differences why that matters.
  • Atypical Antipsychotic Drugs Used to Treat...

    schizophrenia.guide@about.com
    22 Oct 2014 | 4:24 am
    In the early 1990s a new class of drugs were developed to treat the psychotic symptoms of schizophrenia. These drugs, the atypical antipsychotics, have proven generally as effective as the antispychotics developed decades earlier, with fewer extrapyrimidal side effects. This list of the atypical antipsychotics provides links to drug safety information from the drug manufacturers' websites.
  • Who Gets Schizophrenia?

    schizophrenia.guide@about.com
    22 Oct 2014 | 4:24 am
    Although the overall incidence of schizophrenia in the United States is close to 1%, different groups have a greater or lesser likelihood of developing the illness. This article from your About Guide to Schizophrenia reviews the incidence of schizophrenia among different groups of people, which scientists are using as clues to help find the cause.
  • Schizophrenia Symptoms and Diagnosis

    schizophrenia.guide@about.com
    22 Oct 2014 | 4:24 am
    What are the main symptoms of schizophrenia? How is a diagnosis of schizophrenia made?
  • What It's Like to Have Schizophrenia

    schizophrenia.guide@about.com
    22 Oct 2014 | 4:24 am
    In schizophrenia, the most basic processes of perceiving and thinking are affected by the illness. Whether you want your loved ones to understand you better, are concerned for someone who's ill, or are simply curious, this article describes the internal experience of delusions, hallucinations, and more.
 
  • add this feed to my.Alltop

    Schizophrenia Bulletin - Advance Access

  • Multifactoriality in Psychiatric Disorders: A Computational Study of Schizophrenia

    Pavao, R., Tort, A. B. L., Amaral, O. B.
    20 Oct 2014 | 1:44 am
    The search for biological causes of mental disorders has up to now met with limited success, leading to growing dissatisfaction with diagnostic classifications. However, it is questionable whether most clinical syndromes should be expected to correspond to specific microscale brain alterations, as multiple low-level causes could lead to similar symptoms in different individuals. In order to evaluate the potential multifactoriality of alterations related to psychiatric illness, we performed a parametric exploration of published computational models of schizophrenia. By varying multiple…
  • Early Psychosis Intervention Services: A Work in Progress

    Dixon, L., Lieberman, J.
    20 Oct 2014 | 1:18 am
  • Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility

    Kimura, H., Tsuboi, D., Wang, C., Kushima, I., Koide, T., Ikeda, M., Iwayama, Y., Toyota, T., Yamamoto, N., Kunimoto, S., Nakamura, Y., Yoshimi, A., Banno, M., Xing, J., Takasaki, Y., Yoshida, M., Aleksic, B., Uno, Y., Okada, T., Iidaka, T., Inada, T., Suzuki, M., Ujike, H., Kunugi, H., Kato, T., Yoshikawa, T., Iwata, N., Kaibuchi, K., Ozaki, N.
    20 Oct 2014 | 1:18 am
    Background: Nuclear distribution E homolog 1 (NDE1), located within chromosome 16p13.11, plays an essential role in microtubule organization, mitosis, and neuronal migration and has been suggested by several studies of rare copy number variants to be a promising schizophrenia (SCZ) candidate gene. Recently, increasing attention has been paid to rare single-nucleotide variants (SNVs) discovered by deep sequencing of candidate genes, because such SNVs may have large effect sizes and their functional analysis may clarify etiopathology. Methods and Results: We conducted mutation screening of NDE1…
  • Implications for Services and Policy

    Goldman, H., Hogan, M.
    18 Oct 2014 | 1:15 am
  • Methodological Comments: McFarlane et al

    Kraemer, H. C.
    16 Oct 2014 | 5:40 am
    Does the McFarlane et al study1 provide a model for practical trials? Unfortunately, not. The methodological problems are here reviewed and used as a springboard to set out methodological criteria that might define such a model.
  • add this feed to my.Alltop

    Schizophrenia News -- ScienceDaily

  • Aspirin shown to benefit schizophrenia treatment

    20 Oct 2014 | 6:01 am
    Some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments, new research suggests. Research has shown that the immune system is linked to certain psychiatric disorders, such as schizophrenia and bipolar disorder. Research has shown that "antioxidants and anti-inflammatory drugs could not only reduce symptoms associated with the disorders but also prevent the appearance of neurobiological abnormalities and transition to psychosis if given early during brain development," experts say.
  • YouTube as peer support for severe mental illness

    17 Oct 2014 | 3:37 pm
    People with severe mental illness such as schizophrenia, schizoaffective disorder or bipolar disorder use a popular social media website like YouTube to provide and receive naturally occurring peer support, researchers report.
  • Increased health risks linked to first-episode psychosis

    8 Oct 2014 | 5:39 pm
    Many patients with psychosis develop health risks associated with premature death early in the course of their mental illness. Patients with schizophrenia are already known to have higher rates of premature death than the general population. Elevated risks of heart disease and metabolic issues such as high blood sugar in people with first episode psychosis are due to an interaction of mental illness, unhealthy lifestyle behaviors and antipsychotic medications that may accelerate these risks, experts say.
  • Working memory hinders learning in schizophrenia

    7 Oct 2014 | 3:42 pm
    Trouble with working memory makes a distinct contribution to the difficulty people with schizophrenia sometimes have in learning, according to a new study. The researchers employed a specially designed experiment and computational models to distinguish the roles of working memory and reinforcement learning.
  • Schizophrenia, bipolar disorder associated with dendritic spine loss in brain

    2 Oct 2014 | 6:24 am
    Schizophrenia and bipolar disorder both appear to be associated with dendritic spine loss in the brain, suggesting the two distinct disorders may share common pathophysiological features.
 
  • add this feed to my.Alltop

    Schizophrenia Society of Nova Scotia

  • The "From Recovery to Discovery" Mental Health Peer Support Group-Halifax

    22 Oct 2014 | 4:00 am
    Tomorrow, October 23rd, 6:00 pmMeetingsEvery Thursday Evening6:30 pm to 8:30 pmCommunity RoomAtlantic Superstore – Barrington Street 1075 Barrington StreetHalifax, Nova Scotia Plenty of free parking!The Atlantic Superstore – Barrington Street is on the 3, 7, 9, and 41 Metro Transit bus routes.The From Recovery to Discovery Mental Health Peer Support Group is open to anyone affected by any type of mental illness, and this includes family members and friends.Free! Thursday, October 23rd, 2014, 6:00 to 8:00 pmA Community Visitto the Café ScientifiqueNew Approaches in Treatment:…
  • The Schizophrenia Society of Nova Scotia's 26th Annual Conference - The Brain: Mental Health & Psychiatric Disorders

    22 Oct 2014 | 3:30 am
    Friday, November 7th, 20149:00 am to 3:45 pmMcInnes RoomStudent Union Building, Dalhousie University6136 University AvenueHalifax, Nova ScotiaKeynote Speaker"Magnetic Brain Stimulation"Dr. Z. Jeff DaskalakisProfessor of PsychiatryDepartment of PsychiatryUniversity of TorontoandDirectorTemerty Centre for Therapeutic Brain InterventionCentre for Addiction and Mental HealthToronto, Ontario To download Dr. Daskalakis' biosketch (PDF), please click here.Invited Speakers"Early Intervention for Psychotic Disorders - Recent Findings"Dr. Sabina AbidiInterim Associate ChiefDivision of Child &…
  • Of Sound Faith - A peer-led initiative encouraging the healing and recovery of those with experiences in mental illness

    22 Oct 2014 | 3:00 am
    Begins in Halifax Regional Municipality in November 2014For further information or to register, please contact Lesley-Ann Kean, Project Coordinator, Of Sound Faith, by sending an email to ofsoundfaith@live.ca.Please click on the image to magnify it.To download the PDF version of the above flyer, please click here.Of Sound Faith is a project funded through a 2014-2015 Consumer-Led Initiative Grant from the Nova Scotia Department of Health and Wellness.
  • The Kings County Chapter of the SSNS presents "A Beautiful Mind"

    22 Oct 2014 | 2:30 am
    Wednesday, November 5th, 7:00 pmKentville, Nova ScotiaPlease click on the image to magnify it.Also see:Kings County Chapter of the Schizophrenia Society of Nova Scotia
  • Getting Mental Health Crisis Support in Nova Scotia

    21 Oct 2014 | 3:30 am
    Call (902) 429-8167 or 1-888-429-8167 (toll free)The Mental Health Mobile Crisis Team (MHMCT) provides intervention and short term crisis management for children, youth and adults experiencing a mental health crisis. They offer 24/7 telephone intervention throughout Nova Scotia - (902) 429-8167 or 1-888-429-8167 (toll free) - and mobile response (1:00 pm to 1:00 am) in areas served by Halifax Regional Police including Halifax, Dartmouth and Bedford.Note that this video is two years old and it does not mention the 24/7 telephone crisis intervention service that is now available throughout Nova…
  • add this feed to my.Alltop

    schizophrenic.com

  • Men and women at risk for psychosis experience different emotions and symptoms

    M Tyler
    16 Oct 2014 | 2:14 pm
    The subjective experiences of individuals at risk for psychosis differ depending on gender, reports a new study published in Psychiatric Services in Advance. Women seem to be more concerned with past traumas and a family history of psychosis, while men describe feeling alienated and in need of social connection. For the study, researchers conducted interviews with 27 participants who had a significant clinical risk for psychosis. By understanding how both genders cope with their experiences, intervention approaches can better prevent the onset of symptoms or manage the condition in…
  • Higher drug doses needed for pregnant women with psychosis, study finds

    M Tyler
    14 Oct 2014 | 10:08 am
    Pregnant women with psychosis may need higher doses of antipsychotic drugs, or neuroleptics, in order to maintain the drugs' therapeutic effects, a new study reports. Current drugs have been deemed much more safe for pregnant women in terms of side effects, but physicians often reduce dosage anyway. Yet a reduced dosage may put both the mother and unborn child at risk for harm, as untreated symptoms of psychosis can lead to alcohol or drug abuse, increased risk of suicide and relapse of other psychotic symptoms. The therapeutic range For the study, researchers measured levels of aripiprazole…
  • Patients with psychosis have increased risk of potentially fatal health risks

    M Tyler
    10 Oct 2014 | 8:38 am
    Higher risk of heart disease or metabolic syndrome in people with first-episode psychosis can be traced back to the complications of mental illness, reports a new study published in JAMA Psychiatry. The study is one of the fist to reveal results from the National Institute of Mental Health's Recovery After an Initial Schizophrenia Episode (RAISE) project, which examines cases of first-episode psychosis and corresponding treatment results in community settings. The average age of the nearly 400 individuals who were part of the study was only 24 years old, suggesting that patients need early…
  • Problems with working memory makes learning difficult for schizophrenics

    M Tyler
    8 Oct 2014 | 11:45 am
    Learning might be more of challenge for people with schizophrenia based on poorer working memory, according to Brown researchers. In a learning task where patients - 49 with schizophrenia and 36 healthy controls - were shown a set of images that corresponded to particular buttons that needed to be pushed, subjects with schizophrenia had a much harder time recalling which button to push, especially when the researchers increased the amount of images and buttons. With good working memory, the researchers explained, a typical person wouldn't need to see an image more than a few times to remember…
  • Dendric spine loss associated with schizophrenia, bipolar disorder

    M Tyler
    6 Oct 2014 | 10:45 am
    Dendritic spine loss has been linked to both schizophrenia and bipolar disorder, suggesting that the two disorders could share common pathophysiological features, according to research published in JAMA Psychiatry. Dendritic spines are small membrane-like protrusions from a neuron's dendrite that help to transmit signals to the neuron's cell body. Previous studies have found that schizophrenia patients sometimes show spine loss in the dorsolateral prefrontal cortices. Spine density in schizophrenia patients Researchers analyzed the brain tissue in postmortem individuals: 14 with…
  • add this feed to my.Alltop

    Schiz Life

  • Mental Health Laws: Schizophrenia Advocacy

    Schiz Life
    5 Oct 2014 | 12:55 pm
    Twenty to 25% of the homeless populace in the United States have a serious mental illness, including schizophrenia, those with manic outbreaks, and those with severe depressive episodes. The mental health and legal systems are significantly failing these 9.6 million people creating a critical deficiency of services, such as community-based treatment, psychiatric prescriptions, and living accommodations. As a result, police are typically called to deal with incidents or disruptions triggered by the behavior of someone suffering with a serious mental disorder. Jails are the contemporary mental…
  • Is Schizophrenia 8 Distinct Disorders?

    Schiz Life
    18 Sep 2014 | 9:01 am
    We have all likely pondered over the many various types of schizophrenia and the wide range of symptoms that can manifest and realized how different some of them are.  It seems like we might be dealing with several distinct disorders from a surface viewpoint.  There has been little support for this concept “under the hood” when considering neurological and genetic factors, until now. “Multiple Genetically Distinct Disorders” Researchers at the Washington University School of Medicine reported some intriguing results in the American Journal of Psychiatry on the 15th…
  • Amy’s Story: Living with Schizophrenia

    Schiz Life
    6 Sep 2014 | 4:45 pm
    The following is a post by our friend Amy Kay, who has begun, recently and courageously, to voice and share her experiences with schizophrenia on her blog Voice of a Schizophrenic.  We are happy to share her story.. I used to tell people “I have a bad brain.” I am not going to say I suffer from schizophrenia but rather I endure and cope with it. My name is Amy Kay and I have schizophrenia. I do not want to hurt others or myself. Neither do I hear voices and I no longer live in a delusional world. In 2008 during my initial psychiatric breakdown it started with a state of euphoria.
  • New Schizophrenia Dimmer Switch Medication Concept

    Schiz Life
    12 Aug 2014 | 12:51 pm
    As we all know, schizophrenia medication can cause a rash of ill effects in it’s users, often times to the point that the disruption from the medication is subjectively worse than the symptoms of the illness they are meant to treat.  Finding the right balance of medications to properly treat the problem without creating addition side effects can be a long and drawn out process that is frustrating to the patient and the doctor.  However, a breakthrough in this process may have just occurred… Yesterday, the Monash University in Melbourne, Australia published its findings (read the…
  • The 12 Core Functions: Your Therapist and Treatment Path

    Schiz Life
    20 Jul 2014 | 5:43 am
    The 12 Core Functions: Your Therapist and Treatment Path A sad reality is that many people dealing with the symptoms of schizophrenia simply fail to receive treatment.  There are lots of various reasons why this can happen, but one of the reasons is a resistance and fear in not understanding how treatment will transpire.  This article is meant to give the reader a general overview of what the therapist is thinking and the guidelines they follow to perform their task.  Your treatment will be personalized and tailored specifically to your experiences, symptoms, and receptiveness, but it will…
 
Log in